HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 115 | 124 | 92.7% | |
| HF004 | 2020 | 122 | 137 | 89.0% | |
| HF006 | 2021 | 73 | 89 | 82.0% | |
| HF006 | 2022 | 420 | 428 | 98.1% | |
| HF006 | 2023 | 463 | 490 | 94.5% |
